| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/25/2005 | EP1531791A2 Prevention and reduction of blood loss |
| 05/25/2005 | EP1438390A4 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 05/25/2005 | EP1341791B1 Thioether substituted imidazoquinolines |
| 05/25/2005 | EP1286673B1 Ligands of integrin receptors |
| 05/25/2005 | EP1282592B1 Use of amines |
| 05/25/2005 | EP1039911B1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS |
| 05/25/2005 | EP0880362B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist |
| 05/25/2005 | EP0813416B1 Reduction of infarct volume using citicoline |
| 05/25/2005 | CN1620500A Corona-virus-like particles comprising functionally deleted genomes |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620461A 2-amino-propanol derivatives |
| 05/25/2005 | CN1620438A 5, 6-diaryl-pyrazine-2-amide derivatives as CBI antagonists |
| 05/25/2005 | CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors |
| 05/25/2005 | CN1620414A 维生素d类似物 Vitamin d analogues |
| 05/25/2005 | CN1620314A Gas micro-liposome compound |
| 05/25/2005 | CN1620301A Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 05/25/2005 | CN1620293A Polymorphs of clopidogrel hydrogensulfate |
| 05/25/2005 | CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors |
| 05/25/2005 | CN1618455A Traditional Chinese medicine pill for treating cerebral thrombosis, and its prescription |
| 05/25/2005 | CN1203087C Factor VIIa inhibitors |
| 05/25/2005 | CN1203070C Thrombin receptor antagonists |
| 05/25/2005 | CN1202842C Medicine composition for preventing and treating thrombosis and relative disease |
| 05/24/2005 | US6897293 A DNA sequence encoding a gax protein or portion, which inhibits vascular smooth muscle cell proliferation, useful in the treatment of blood vessel diseases |
| 05/24/2005 | US6897235 Compositions useful for the treatment of pathologies responding to the activation of PPAR-γ receptor |
| 05/24/2005 | US6897222 Pyrido[2,1-a]isoquinoline derivatives |
| 05/24/2005 | US6897060 Composition comprising multipotent neural stem cells for generation of hematopoietic cells |
| 05/24/2005 | US6897039 For treatment of cardiovascular diseases. |
| 05/24/2005 | CA2157792C N-(3-piperidinyl-carbonyl)-beta-alanine derivatives as paf antagonists |
| 05/24/2005 | CA2155840C Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
| 05/24/2005 | CA1341484C Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 05/19/2005 | WO2005002617A3 Use of compositions comprising a soluble form of hla-g in the treatment of blood diseases |
| 05/19/2005 | WO2004106934A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 05/19/2005 | WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 05/19/2005 | WO2003009815A3 Compositions and methods for modulating blood-brain barrier transport |
| 05/19/2005 | US20050108784 Expression vector comprising nucleotide sequences coding spinocerebellar ataxia-1 gene for use in treatment and prevention of nervous system disorders |
| 05/19/2005 | US20050107472 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles |
| 05/19/2005 | US20050107452 Black soybean polysaccharides |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 05/19/2005 | US20050107416 17-hydroxy 4-aza androstan -3-ones as androgen receptor modulators |
| 05/19/2005 | US20050107413 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 05/19/2005 | US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders |
| 05/19/2005 | US20050107372 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/19/2005 | US20050107362 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
| 05/19/2005 | US20050107357 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106676 Novel proteins having hemolytic activity and genes encoding the protein |
| 05/19/2005 | US20050106658 Remodeling and glycoconjugation of peptides |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/19/2005 | US20050106212 Using electrochemical mixture of metal compound and bioactive material; contacting substrate |
| 05/19/2005 | US20050106211 Fabrication of drug loaded biodegradable polymer fibers |
| 05/19/2005 | US20050106148 Method of treating blood disorders |
| 05/19/2005 | US20050106127 Graft to humans; culture product; removing cells; preservation |
| 05/19/2005 | US20050106126 Compositions including ammonia oxidizing bacteria and methods of using same |
| 05/19/2005 | US20050106099 Fusion proteins |
| 05/18/2005 | EP1530725A1 Materials and methods for inductions of immune tolerance |
| 05/18/2005 | EP1530632A2 Growth factor which acts through erb b-4 rtk |
| 05/18/2005 | EP1530593A1 Highly branched, unsubstituted or low-substituted starch products, dialysis solution and plasma expander containing the same, and the use thereof |
| 05/18/2005 | EP1530586A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/18/2005 | EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 05/18/2005 | EP1530566A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530473A2 Regulation of erythrocyte apoptosis |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1161530B1 Protein for blocking platelet adhesion |
| 05/18/2005 | CN1617735A Storage-stable fibrin sealant |
| 05/18/2005 | CN1616076A Medicine for treating cardiocerebral vascular system disease and blood supply deficiency, medicine preparing method and preparation |
| 05/18/2005 | CN1616067A Shuxuening freeze-dried preparation for ingection and its preparing method |
| 05/18/2005 | CN1616066A Shuxuening transfusion fluid and its preparing method |
| 05/18/2005 | CN1616025A Chinese medicine for preventing hemolysis, preventing miscarriage and tonifying brain to prevent blood group incompatibility hemolysis disease in pregnancy |
| 05/18/2005 | CN1615995A Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method |
| 05/18/2005 | CN1615991A Medicine for treating hemorrhagic disease and its preparing method |
| 05/18/2005 | CN1615980A Active extract of lamtophlomis rotata and its preparing method and use |
| 05/18/2005 | CN1615922A Chinese herbal medicine preparation for treating aplastic anemia |
| 05/18/2005 | CN1615908A Absorbent for oral administration, and agent for treating or preventing renal or liver disease |
| 05/18/2005 | CN1615872A Ginkgo-dipyridamole for injection and its preparing process |
| 05/18/2005 | CN1615869A Flunarizine hydrochloride injection and its preparing method |
| 05/18/2005 | CN1615839A Utilization of dialkylfumarates |
| 05/18/2005 | CN1615836A Rubidate soft capsule and its preparing method |
| 05/18/2005 | CN1202103C Preparation method of red sageroot total phenolic acid |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1201812C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 05/18/2005 | CN1201787C Medicine for curing thrombotic phlebitis |
| 05/18/2005 | CN1201764C Chinese medicine oil preparation for promoting blood circulation |
| 05/18/2005 | CN1201740C Intermittent claudication therapeutic drugs comprising phyrroloazepines |
| 05/18/2005 | CN1201731C Medicine preparation and its use and the use of high grade primary alcohol mixture |
| 05/17/2005 | US6894168 Carbamoyl tetrahydropyridine derivatives |
| 05/17/2005 | US6894165 Imidazonaphthyridines |
| 05/17/2005 | US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders |
| 05/17/2005 | US6894067 5-heteroatom-substituted pyrazoles |
| 05/17/2005 | US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases |
| 05/17/2005 | US6894051 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 05/17/2005 | US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes |
| 05/17/2005 | US6894036 4-dedimethylaminotetracycline derivatives |
| 05/17/2005 | US6893856 Generating preferential compounds in sample; obtain sample, perform solid phase extraction, elute, recover compounds |
| 05/17/2005 | US6893642 Anticancer nutraceutical from spirulina |
| 05/17/2005 | US6893641 Ganoderma lucidum spores for treatment of autoimmune diseases |